17.05.2017 21:00:00
|
IDEXX Laboratories to Present at Stifel 2017 Dental and Veterinary Conference
WESTBROOK, Maine, May 17, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the Stifel Dental and Veterinary Conference. Jay Mazelsky, Executive Vice President, and Brian McKeon, Executive Vice President and Chief Financial Officer, will present on Wednesday, May 31, 2017 at 12:40 p.m. (EDT), at the Peninsula Hotel, New York. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archived edition of the presentation will be available via the same link.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of Standard & Poor's 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.
Contact:
Investor Relations:
Kerry Bennett
207-556-8155
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/idexx-laboratories-to-present-at-stifel-2017-dental-and-veterinary-conference-300459510.html
SOURCE IDEXX Laboratories, Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
17.02.25 |
NASDAQ Composite Index-Wert IDEXX Laboratories-Aktie: So viel Gewinn hätte ein Investment in IDEXX Laboratories von vor 5 Jahren eingefahren (finanzen.at) | |
14.02.25 |
Handel in New York: NASDAQ 100 zum Ende des Freitagshandels in der Gewinnzone (finanzen.at) | |
10.02.25 |
NASDAQ Composite Index-Wert IDEXX Laboratories-Aktie: So viel Verlust hätte eine IDEXX Laboratories-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
03.02.25 |
Schwacher Wochentag in New York: NASDAQ Composite beendet den Handel im Minus (finanzen.at) | |
03.02.25 |
Schwacher Handel in New York: NASDAQ 100 zum Ende des Montagshandels schwächer (finanzen.at) | |
03.02.25 |
Verluste in New York: S&P 500 verbucht zum Handelsende Verluste (finanzen.at) | |
03.02.25 |
Verluste in New York: NASDAQ Composite nachmittags in Rot (finanzen.at) | |
03.02.25 |
Handel in New York: S&P 500 legt den Rückwärtsgang ein (finanzen.at) |
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 432,10 | 0,23% |
|